In a first-of-its-kind study, Vesalius proves that its catheter-based anchoring to the papillary muscle is safe and durable

PRADAXA is the first approved oral alternative to warfarin in over 50 years to reduce the risk of stroke in patients with AFib not caused by a heart valve problem. PRADAXA is not for use in people with artificial heart valves.